Tenax Therapeutics, Inc. (TENX)
10.69
-1.15
(-9.71%)
USD |
NASDAQ |
Mar 06, 16:00
10.75
+0.06
(+0.56%)
After-Hours: 20:00
Tenax Therapeutics EPS Diluted (Quarterly) : -0.3977 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.80M |
| Total Expenses (Quarterly) | 15.80M |
| Enterprise Value | -32.62M |
| Earnings Yield | -10.61% |
| Normalized Earnings Yield | -10.61 |